
Opinion|Videos|January 17, 2025
Key Unmet Needs in IPF and PPF
Author(s)Anna Podolanczuk, M.D., M.S.
Anna Podolanczuk, M.D., M.S., discusses the key unmet needs in diagnosing idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), and how artificial intelligence (AI) could play a transformative role in enabling earlier detection of these diseases in the future.
Advertisement
Episodes in this series

Video content above is prompted by the following:
What are the key unmet needs in diagnosing IPF and PPF, and how do you see AI impacting earlier detection of the disease in the future?
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
3 things to know about CVS Health’s 2025 earnings
2
Women show greater dementia risk reduction from shingles vaccine
3
UK study to evaluate sleep app data as early indicator of respiratory disease trends
4
The invisible cost system: Why health plans keep missing millions in print and mail savings
5
























